These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24773376)

  • 1. Syntheses and N-methyl-D-aspartate receptor antagonist pharmacology of fluorinated arylcycloheptylamines.
    Sun S; Wallach J; Adejare A
    Med Chem; 2014; 10(8):843-52. PubMed ID: 24773376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
    Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
    J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological evaluation of 4a-phenanthrenamine derivatives acting at the phencyclidine binding site of the N-methyl-D-aspartate receptor complex.
    Bigge CF; Malone TC; Hays SJ; Johnson G; Novak PM; Lescosky LJ; Retz DM; Ortwine DF; Probert AW; Coughenour LL
    J Med Chem; 1993 Jul; 36(14):1977-95. PubMed ID: 8336337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.
    Parsons CG; Quack G; Bresink I; Baran L; Przegalinski E; Kostowski W; Krzascik P; Hartmann S; Danysz W
    Neuropharmacology; 1995 Oct; 34(10):1239-58. PubMed ID: 8570022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chiral synthesis and pharmacological evaluation of NPS 1407: a potent, stereoselective NMDA receptor antagonist.
    Moe ST; Smith DL; DelMar EG; Shimizu SM; Van Wagenen BC; Balandrin MF; Chien YE; Raszkiewicz JL; Artman LD; White HS; Mueller AL
    Bioorg Med Chem Lett; 2000 Nov; 10(21):2411-5. PubMed ID: 11078190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.
    Subramaniam S; Donevan SD; Rogawski MA
    J Pharmacol Exp Ther; 1996 Jan; 276(1):161-8. PubMed ID: 8558426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.
    Wlaź P
    Brain Res Bull; 1998 Aug; 46(6):535-40. PubMed ID: 9744291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex.
    Tricklebank MD; Bristow LJ; Hutson PH; Leeson PD; Rowley M; Saywell K; Singh L; Tattersall FD; Thorn L; Williams BJ
    Br J Pharmacol; 1994 Nov; 113(3):729-36. PubMed ID: 7858861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on cerebral protective agents. IX. Synthesis of novel 1,2,3,4-tetrahydroisoquinolines as N-methyl-D-aspartate antagonists.
    Ohkubo M; Kuno A; Katsuta K; Ueda Y; Shirakawa K; Nakanishi H; Nakanishi I; Kinoshita T; Takasugi H
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):95-102. PubMed ID: 8582046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and binding properties of MK-801 isothiocyanates; (+)-3-isothiocyanato-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten- 5,10-imine hydrochloride: a new, potent and selective electrophilic affinity ligand for the NMDA receptor-coupled phencyclidine binding site.
    Linders JT; Monn JA; Mattson MV; George C; Jacobson AE; Rice KC
    J Med Chem; 1993 Aug; 36(17):2499-507. PubMed ID: 8355251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzoazepine derivative as potent antagonists of the glycine binding site associated to the NMDA receptor.
    Di Fabio R; Micheli F; Baraldi D; Bertani B; Conti N; Dal Forno G; Feriani A; Donati D; Marchioro C; Messeri T; Missio A; Pasquarello A; Pentassuglia G; Pizzi DA; Provera S; Quaglia AM; Sabbatini FM
    Farmaco; 2003 Sep; 58(9):723-38. PubMed ID: 13679166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-evaluation of phencyclidine low-affinity or "non-NMDA" binding sites.
    Hirbec H; Mausset AL; Kamenka JM; Privat A; Vignon J
    J Neurosci Res; 2002 May; 68(3):305-14. PubMed ID: 12111860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phencyclidine and related compounds evoked [3H]dopamine release from rat mesencephalic cell cultures by a mechanism independent of the phencyclidine receptor, sigma binding site, or dopamine uptake site.
    Mount H; Boksa P; Chaudieu I; Quirion R
    Can J Physiol Pharmacol; 1990 Sep; 68(9):1200-6. PubMed ID: 1980428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant 1-phenylcycloalkylamines: two analogues with low motor toxicity when orally administered.
    Blake PA; Yamaguchi S; Thurkauf A; Rogawski MA
    Epilepsia; 1992; 33(1):188-94. PubMed ID: 1531130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivatives of dexanabinol. II. Salts of amino acid esters containing tertiary and quaternary heterocyclic nitrogen with increased water-solubility.
    Pop E; Soti F; Brewster ME; Barenholz Y; Korablyov V; Mechoulam R; Nadler V; Biegon A
    Pharm Res; 1996 Mar; 13(3):469-75. PubMed ID: 8692744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro.
    Murray F; Kennedy J; Hutson PH; Elliot J; Huscroft I; Mohnen K; Russell MG; Grimwood S
    Eur J Pharmacol; 2000 Jun; 397(2-3):263-70. PubMed ID: 10844123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant activity of novel derivatives of 2- and 3-piperidinecarboxylic acid in mice and rats.
    Hinko CN; Crider AM; Kliem MA; Steinmiller CL; Seo TH; Ho B; Venkatarangan P; el-Assadi AA; Chang H; Burns CM; Tietz EI; Andersen PH; Klitgaard H
    Neuropharmacology; 1996; 35(12):1721-35. PubMed ID: 9076751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists.
    French ED; Mura A; Wang T
    Synapse; 1993 Feb; 13(2):108-16. PubMed ID: 8446919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
    Massieu L; Thedinga KH; McVey M; Fagg GE
    Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.